Site-directed mutagenesis at 134/135 in human growth hormone alters its in vivo half-life in the rat

Biochem Mol Biol Int. 1996 Apr;38(5):981-6.

Abstract

It has been shown that human growth hormone (hGH) is attacked and digested at Arg(134)-Thr(135) by thrombin and plasmin, facilitating its further degradation in the plasma and tissues. To investigate the roles of the amino acids residues on the 134/135 site in the stability and half-life of the hormone in vivo, we have synthesized a mutant hGH, hGH(R134H, T135E), where Arg and Thr are replaced by His and Glu respectively. The mutant hGH showed an altered half-life time (7 min) as compared to that (11 min) for native form hGH, while the biological activity was not affected by the mutation.

MeSH terms

  • Animals
  • Half-Life
  • Human Growth Hormone / genetics*
  • Human Growth Hormone / pharmacokinetics
  • Humans
  • Mutagenesis, Site-Directed
  • Point Mutation
  • Rats

Substances

  • Human Growth Hormone